Tetra Pharm Technologies

About Tetra Pharm Technologies

TETRAPHARM is a Danish biopharmaceutical company focused on developing pharmaceutical drugs targeting the central nervous system (CNS) and immune system to treat neurological diseases and mental health disorders. The company aims to improve quality of life through scientific innovation and operates as a sustainable business committed to positive societal impact.

Products & Services

R&D Pipeline:Multiple drug candidates in clinical development for obesity (with neurological focus), chronic pain, Alzheimer's, and mental health disorders.

CDMO Services:End-to-end Contract Development and Manufacturing Organization solutions using proprietary ZYNDIKATE(r) drug delivery technology, supporting clients from early development to commercialization.

Specialties

Central Nervous System (CNS) therapies Immune system drug development Neurological diseases treatment Mental health disorder treatment Drug delivery innovation Neuroscience

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series A T: - FT: Series A	A: 9747000 MR: - FA: €9 million FAN: 9747000	D: 2023-01-26 FD: 2023-01-26	5 investors

Series A Latest

2023-01-26

$9.7M

5 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

M

Martin Rose

Co-Founder

LinkedIn (Pro only)

J

Jesper Breum

Chief Quality Officer & Co-founder

LinkedIn (Pro only)

M

Morten Allesø

Chief Scientific Officer

J

Jens Mikkelsen

Chief Development Officer

K

Kirsten Harting

Chief Medical Officer

M

Martin Caspersen

Chief Commercial Officer

View 4 more team members with Pro

Unlock Full Team Directory

Recent News